Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) EBT Margin (2017 - 2026)

Updated

Crinetics Pharmaceuticals' EBT Margin was -479.46% in Q2 2026, down 11695.47 percentage points from 11216.00% a year earlier but up 710.34 percentage points from the prior quarter.

Analysis

Crinetics Pharmaceuticals (CRNX) EBT Margin (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Crinetics Pharmaceuticals' EBT Margin was -1188.14% through Jun 30, 2026, down 5138.43 percentage points year-over-year; for FY2025, it came in at -6043.88%, up 22631.58 percentage points from FY2024.

  • EBT Margin shows a five-year change of +97916.68 percentage points (FY2020 to FY2025).
  • In earlier years, EBT Margin was -28675.46% in FY2024 (-23459.14 pp), -5216.32% in FY2023 (-8655.38 pp), 3439.05% in FY2022 (+13424.30 pp) and -9985.25% in FY2021 (+93975.31 pp).
  • Quarterly EBT Margin has moved between -90972.73% (Q3 2025) and 26807.20% (Q1 2025) over five years.
  • Compared with a year earlier, EBT Margin was higher in 1 of the last four quarters, with an average year-over-year change of -7653.45 percentage points.
  • The best year-over-year quarter for EBT Margin over five years was Q4 2022 (a gain of 23459.61 percentage points); the worst was Q1 2026 (a drop of 27997.01 percentage points).
  • Per Business Quant data, CRNX's EBT Margin in the three quarters before Q2 2026 was -1189.81% (Q1 2026), -1990.50% (Q4 2025) and -90972.73% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn -479.46%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -479.46%
Mar 31, 2026 -1,189.81%
Dec 31, 2025 -1,990.50%
Sep 30, 2025 -90,972.73%
Jun 30, 2025 11,216.00%
Mar 31, 2025 26,807.20%
Jun 30, 2024 18,560.15%
Mar 31, 2024 10,384.38%
Sep 30, 2023 16,318.21%
Jun 30, 2023 5,159.82%
Mar 31, 2023 1,716.87%
Dec 31, 2022 6,345.70%
Sep 30, 2022 9,153.93%
Jun 30, 2022 9,652.62%
Mar 31, 2022 1,073.68%
Dec 31, 2021 -17,113.91%
Mar 31, 2020 -24,261.97%
Dec 31, 2019 -4,535.51%
Sep 30, 2019 -2,850.30%
Mar 31, 2019 -2,461.58%
API Access

Crinetics Pharmaceuticals EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=CRNX&period=max&api_key=YOUR_API_KEY